Literature DB >> 8707966

Granulomatous disease in common variable immunodeficiency: effect on immunoglobulin replacement therapy and response to steroids and splenectomy.

G P Spickett1, J G Zhang, T Green, J Shrimankar.   

Abstract

A 40 year old white woman with common variable immunodeficiency of four years duration presented with rapidly increasing splenomegaly. Despite high dose, weekly intravenous immunoglobulin, it was impossible to raise the trough serum IgG concentration to within the normal range. While waiting for a diagnostic splenectomy, low dose corticosteroids were started, leading to a decrease in the size of the spleen and an increase in the trough IgG concentration. Both spleen and liver showed non-caseating granulomas. Following splenectomy, the corticosteroids were tailed off and the trough IgG was maintained well into the normal range on a reduced, fortnightly dose of intravenous immunoglobulin and a low dose of oral corticosteroid.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707966      PMCID: PMC500491          DOI: 10.1136/jcp.49.5.431

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

Review 1.  Cellular abnormalities in common variable immunodeficiency.

Authors:  G P Spickett; A D Webster; J Farrant
Journal:  Immunodefic Rev       Date:  1990

Review 2.  Primary antibody deficiency in adults.

Authors:  G P Spickett; S A Misbah; H M Chapel
Journal:  Lancet       Date:  1991-02-02       Impact factor: 79.321

3.  Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications.

Authors:  R A Hermaszewski; A D Webster
Journal:  Q J Med       Date:  1993-01

4.  Splenic lesions in hypogammaglobulinaemia.

Authors:  J Weston; B M Balfour; W Tsohas; N English; J Farrant; A D Webster
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

5.  [Common variable immunodeficiency and sarcoidosis].

Authors:  A Ortiz Arduán; F J Sanz del Forcallo; J Carreira Delgado; R García Delgado; F Ortiz Masllorréns; J M Castrillo García; M Jiménez Casado
Journal:  Rev Clin Esp       Date:  1992-02       Impact factor: 1.556

6.  Sarcoidosis associated with combined immunodeficiency.

Authors:  M J Crofts; M V Joyner; J C Sharp; J Costello; D Vergani
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

Review 7.  Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.

Authors:  H M Chapel
Journal:  BMJ       Date:  1994-02-26

8.  Sarcoidosis and primary hypogammaglobulinaemia: a report of two cases and a review of the literature.

Authors:  C L Leen; J C Bath; R P Brettle; P L Yap
Journal:  Sarcoidosis       Date:  1985-09
  8 in total
  8 in total

Review 1.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

3.  Anti-D immunoglobulin treatment for thrombocytopenia associated with primary antibody deficiency.

Authors:  H J Longhurst; C O'Grady; G Evans; C De Lord; A Hughes; J Cavenagh; M R Helbert
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

4.  Deficiency in circulating natural killer (NK) cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia.

Authors:  R M Aspalter; W A Sewell; K Dolman; J Farrant; A D Webster
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

Review 5.  Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii.

Authors:  S Mrusek; A Marx; J Kummerle-Deschner; N Tzaribachev; A Enders; U-N Riede; K Warnatz; G E Dannecker; S Ehl
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 6.  Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients.

Authors:  Jean-Nicolas Boursiquot; Laurence Gérard; Marion Malphettes; Claire Fieschi; Lionel Galicier; David Boutboul; Raphael Borie; Jean-François Viallard; Pauline Soulas-Sprauel; Alice Berezne; Arnaud Jaccard; Eric Hachulla; Julien Haroche; Nicolas Schleinitz; Laurent Têtu; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2012-09-18       Impact factor: 8.317

Review 7.  Common variable immunodeficiency.

Authors:  W Strober; K Chua
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 10.817

8.  What Works When Treating Granulomatous Disease in Genetically Undefined CVID? A Systematic Review.

Authors:  Astrid C van Stigt; Willem A Dik; Lieke S J Kamphuis; Bas M Smits; Joris M van Montfrans; P Martin van Hagen; Virgil A S H Dalm; Hanna IJspeert
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.